Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesNabi Biopharmaceuticals Receives Grant Supporting Further NicVAX Development
Nabi Biopharmaceuticals, 09/30/09
Nabi Biopharmaceuticals and the U.S. National Institute on Drug Abuse, part of the National Institutes of Health, announced that NIDA has agreed to extend its support for the continued development of NicVAX(R), Nabi's proprietary vaccine to treat nicotine addiction and prevent smoking relapse. In conjunction with the grant, the Company has decided to proceed with the first pivotal phase III trial, while advancing strategic partnering discussions for the future development and commercialization of NicVAX.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Sponsor
Article Search
Sponsor